ForeignExchange Translations and euroscript International have announced that they have signed an equity purchase agreement pursuant to which Luxembourg-based euroscript, a leading provider of global content management solutions, will acquire ForeignExchange, the leader in medical translations . The acquisition is expected to be completed by the end of May 2015.
The two companies are very complementary in the makeup of each firm’s client list, product and services offerings, and market penetration across key geographical areas within the life sciences industry. euroscript brings technology focus, a global presence and experience in enterprise regulated content, document and compliance management solutions, while ForeignExchange offers language-service expertise in the medical device and pharmaceutical markets with a strong global client base.
“We are so pleased and excited to welcome Andres Heuberger and his worldwide team to the euroscript family” said Mark Evenepoel, CEO of euroscript. “With the combined talents of our respective employees, and the integration of our technologies and services, our companies will be able to respond to a much wider array of customer needs. The acquisitions of ForeignExchange and Infotehna, the leading vendor of regulatory information, document and process management solutions, which euroscript acquired last year, creates a unique offering addressing the life sciences industry specific global challenges and enabling clients to ensure the quality, efficacy and safety of their products.”
Andres Heuberger, CEO for ForeignExchange, adds “We’re proud of our reputation, our clients and our many achievements. ForeignExchange has experienced impressive growth and this acquisition will fuel further growth while allowing us to remain focused on our clients’ diverse requirements.”
The combined companies will employ 1,700 full time employees globally spread throughout 23 countries.
About ForeignExchange Translations, Inc.
Founded in 1998, ForeignExchange Translations leads the medical translation industry, partnering exclusively with medical device, pharmaceutical and biotech organizations throughout the world. With its international teams of doctors, scientists and linguists, ForeignExchange helps the world’s largest drug and device companies reduce time to market, comply with international regulations, avoid risks, and save lives. Current clients include global medical enterprises such as Johnson & Johnson, Abbott, Novartis, and St. Jude Medical. For more information, visit http://www.fxtrans.com
Follow us on LinkedIn: https://www.linkedin.com/company/foreignexchange-translations
About euroscript International, S.A
euroscript is a leading provider of global content lifecycle management solutions. euroscript divisions deliver comprehensive solutions that help customers design, build and run content management operations of all sizes. Thanks to its employees’ expertise in the fields of consulting, system integration, language services as well as content and document management, euroscript is able to help businesses worldwide to manage content more efficiently. In its 2014 Language Services Market Report Common Sense Advisory ranks euroscript as the 7th largest language services firm globally. With a market presence in 21 countries, euroscript serves customers in a variety of business sectors, including the public sector, aerospace, defense and transport, manufacturing, life sciences, financial services as well as energy and environment. For more information, visit http://www.euroscript.com
Follow us on LinkedIn: https://www.linkedin.com/company/euroscript-international